0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market [Yahoo! Finance]

Edwards Lifesciences Corporation (EW)  More Company Research Source: Yahoo! Finance
Last edwards lifesciences corporation earnings: 4/23 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com
Cardiovascular disease may be one of medicine's oldest battlegrounds , but some of its most important technologies are still evolving — and not always as quickly as patients, and investors, might expect. Nowhere is that more evident than in transcatheter aortic valve replacement (TAVR), a market dominated for more than a decade by two global giants: Edwards Lifesciences Corp (NYSE:EW, XETRA:EWL) and Medtronic PLC (NYSE:MDT, XETRA:2M6) . Their flagship devices — Sapien and Evolut — have transformed the treatment of aortic stenosis , a life-threatening narrowing of the aortic valve that restricts blood flow and can lead to heart failure or death if left untreated. Yet those devices, for all their success, still reflect incremental design changes — and force clinicians to navigate trade-offs between ease of use and optimal performance. At the same time, their expanded use in lower-risk and younger patient populations is creating a new unmet need, as patients live longer and, in some [Read more]
IMPACT SNAPSHOT EVENT TIME: EW
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
EW alerts
from News Quantified
EW
NEWS
EW
Earnings
EW
Analyst Actions
EW
SEC Filings
Stockreport

A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market [Yahoo! Finance]

Edwards Lifesciences Corporation  (EW) 
More Company Research Source: Yahoo! Finance
Last edwards lifesciences corporation earnings: 4/23 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com
Cardiovascular disease may be one of medicine's oldest battlegrounds , but some of its most important technologies are still evolving — and not always as quickly as patients, and investors, might expect. Nowhere is that more evident than in transcatheter aortic valve replacement (TAVR), a market dominated for more than a decade by two global giants: Edwards Lifesciences Corp (NYSE:EW, XETRA:EWL) and Medtronic PLC (NYSE:MDT, XETRA:2M6) . Their flagship devices — Sapien and Evolut — have transformed the treatment of aortic stenosis , a life-threatening narrowing of the aortic valve that restricts blood flow and can lead to heart failure or death if left untreated. Yet those devices, for all their success, still reflect incremental design changes — and force clinicians to navigate trade-offs between ease of use and optimal performance. At the same time, their expanded use in lower-risk and younger patient populations is creating a new unmet need, as patients live longer and, in some [Read more]
IMPACT SNAPSHOT
EVENT TIME:
EW
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS